5-chloro-N4-(1-ethyl-3-(isopropylsulfonyl)-1H-pyrazol-4-yl)-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)pyrimidine-2,4-diamine

ID: ALA3787103

Chembl Id: CHEMBL3787103

PubChem CID: 127032501

Max Phase: Preclinical

Molecular Formula: C27H38ClN7O3S

Molecular Weight: 576.17

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCn1cc(Nc2nc(Nc3cc(C)c(C4CCNCC4)cc3OC(C)C)ncc2Cl)c(S(=O)(=O)C(C)C)n1

Standard InChI:  InChI=1S/C27H38ClN7O3S/c1-7-35-15-23(26(34-35)39(36,37)17(4)5)31-25-21(28)14-30-27(33-25)32-22-12-18(6)20(13-24(22)38-16(2)3)19-8-10-29-11-9-19/h12-17,19,29H,7-11H2,1-6H3,(H2,30,31,32,33)

Standard InChI Key:  NNNQIXXZLQIIFE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3787103

    ---

Associated Targets(Human)

ALK Tclin ALK tyrosine kinase receptor (7132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 576.17Molecular Weight (Monoisotopic): 575.2445AlogP: 5.58#Rotatable Bonds: 10
Polar Surface Area: 123.06Molecular Species: BASEHBA: 10HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.73CX Basic pKa: 10.34CX LogP: 4.70CX LogD: 2.76
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.28Np Likeness Score: -1.31

References

1. Zhang P, Dong J, Zhong B, Zhang D, Yuan H, Jin C, Xu X, Li H, Zhou Y, Liang Z, Ji M, Xu T, Song G, Zhang L, Chen G, Meng X, Sun D, Shih J, Zhang R, Hou G, Wang C, Jin Y, Yang Q..  (2016)  Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.,  26  (8): [PMID:26979157] [10.1016/j.bmcl.2016.03.017]

Source